Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
33%
Ph phase_4
1
17%
Ph phase_3
2
33%
Ph phase_2
1
17%

Phase Distribution

0

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
2(33.3%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(3)
Other(1)

Detailed Status

Completed3
Recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (16.7%)
Phase 32 (33.3%)
Phase 41 (16.7%)
N/A2 (33.3%)

Trials by Status

recruiting233%
completed350%
unknown117%

Recent Activity

2 active trials
Showing 5 of 6
recruitingphase_4

Identifying and Treating Depression in the Orthopaedic Trauma Population

NCT05976347
completedphase_2

Clinical Study to Evaluate the Possible Efficacy of Dapagliflozin and Atorvastatin in Patients With Major Depressive Disorders

NCT05792540
recruitingphase_3

Repurposed Approved and Under Development Therapies for Patients With Early-Onset COVID-19 and Mild Symptoms

NCT04727424
unknownnot_applicable

Selective Serotonin Reuptake Inhibitors, Fluoxetine Versus the Standard Oral Desmopressin for Management of Mono-symptomatic Nocturnal Enuresis.

NCT06185361
completednot_applicable

Comparison of Fluoxetine Versus Citalopram Therapy to Control Postmenopausal Vasomotor Syndrome

NCT05346445
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT05976347Phase 4

Identifying and Treating Depression in the Orthopaedic Trauma Population

Recruiting
NCT05792540Phase 2

Clinical Study to Evaluate the Possible Efficacy of Dapagliflozin and Atorvastatin in Patients With Major Depressive Disorders

Completed
NCT04727424Phase 3

Repurposed Approved and Under Development Therapies for Patients With Early-Onset COVID-19 and Mild Symptoms

Recruiting
NCT06185361Not Applicable

Selective Serotonin Reuptake Inhibitors, Fluoxetine Versus the Standard Oral Desmopressin for Management of Mono-symptomatic Nocturnal Enuresis.

Unknown
NCT05346445Not Applicable

Comparison of Fluoxetine Versus Citalopram Therapy to Control Postmenopausal Vasomotor Syndrome

Completed
NCT02569970Phase 3

Efficacy of Fluoxetine Against Seizure-induced Central Apneas

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6